Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$70.23 - $86.01 $584,243 - $715,517
8,319 New
8,319 $601,000
Q2 2022

Jul 12, 2022

BUY
$66.18 - $83.18 $326,201 - $409,994
4,929 New
4,929 $374,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Heartland Bank & Trust CO Portfolio

Follow Heartland Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Bank & Trust CO with notifications on news.